References 1. Hess, L.M. and Pohl, G. Perspectives of qual- ity care in cancer treatment: a review of the literature. AHDB 2013, 6(6), 321–9.
2. Mavroudi, M.; Zarogoulidis, P. et al. Stem cells’ guided gene therapy of cancer: new frontier in personalized and targeted ther- apy. J. Cancer Res. Ther. 2014, 2, 22–33.
3. Berrueta, L.A.; Gallo, B. et al. A review of solid phase extraction: basic principles and new developments. Chromatographia 1995, 40(7/8), 474–83.
4. Allanson, J.P.; Biddlecombe, R.A. et al. The use of automated solid phase extraction in the “96 well” format for high throughput bioanalysis using liquid chromatography coupled to tandem mass spectrometry. Rapid Commun. Mass SP 1996, 10, 811–16.
5. Marinova, M.; Artusi, C.; et al. Immunosup- pressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood sam- ples. Clin. Biochem. 2013, 46, 1723–7.
6. Junginger, S. and Thurow, K. Automatisierte festphasenextraktionseinheit mit positivem Druck (automated solid phase extraction unit with positive Druc). Jahresbericht, Nachwuchsgruppe LSA Systems & Process Technologies, 2014, 1–5.
7. Elkhalifa, A.S. and Weiner, H.L. Cyclophos- phamide treatment of MS: current thera- peutic approaches and treatment regi- mens. The International MS Journal 2010, 17, 12–18.
8. Tashkin, D.P.; Elashoff, R. et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am. J. Resp. Crit. Care 2007, 176, 1026–34.
9. Singh, N.; Nigam, M. et al. Caspase medi- ated enhanced apoptotic action of cyclo- phosphamide and resveratrol-treated MCF-7 cells. J. Pharmacol. Sci. 2009, 109, 473 – 85.
10. Nilsson, K.; Andersson, M. et al. Phospho- lipid removal combined with a semi-auto- mated 96-well SPE application for deter- mination of budesonide in human plasma with LC-MS/MS. J. Chromatogr. B 2014, 970, 31–5.
www.emdmillipore.com/move-disinfection-control EMD Millipore is a division of Merck KGaA, Darmstadt, Germany
MERC150037_ad_emd_spectroquant_move_disinfection_control_127x171.indd 1 AMERICAN LABORATORY • 33 • MARCH 2015 20.02.15 14:58
Test. Trust. Move. Spectroquant® Move Cl2
mobile colorimeter Test
at the click of a button using all parameters for disinfection control with one instrument.
– Simplify disinfection control. Trust
your results with our secure, simplified Analytical Quality Assurance and enhanced documentation.
– Secure rapid, reliable results. Move
your water analysis anywhere – even to wet or dusty environments – thanks to IP 68 classification.
– Move your analysis anywhere.
11. Chen, X.-H.; Franke, J.-P. et al. Pitfalls and solutions in the development of a fully auto- mated solid-phase extraction method for drug screening purposes in plasma and whole blood. J. Anal. Toxicol. 1993, 17, 421–6.
Carolin Gallert, Ellen Vorberg, Thomas Roddel- kopf and Kerstin Thurow are with the Center for Life Science Automation (celisca), University of Rostock, Friedrich-Barnewitz Str. 8, D-18119
Rostock, Germany; tel.: +49 381 498 7803; fax: +49 381 498 7802; e-mail:
carolin.gallert@
celisca.de. Steffen Junginger and Heidi Fleischer are with the Institute of Automation (IAT), University of Ros- tock, Rostock, Germany. The authors wish to thank the Federal Ministry of Education and Research (BMBF, Bonn, Germany) for financial support (FKZ: 03Z1KN11), and Mrs. Grit Koch (University of Ros- tock) for her excellent technical assistance.
/O3
/ClO2
/CyA/pH
NEW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56